Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01415492 · ClinicalTrials.gov registry record · NA

Multiple Risk Behavior Intervention in Health Care Settings

A NA study of Health Behavior and Risk Reduction Behavior, sponsored by Dana-Farber Cancer Institute.

Completed
Registry status
NA
Development phase
2,440
Enrollment target
1
Study location

NCT01415492: Completed NA study of Health Behavior and Risk Reduction Behavior, sponsored by Dana-Farber Cancer Institute.

NCT01415492 is a NA study of Health Behavior and Risk Reduction Behavior that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 2,440 participants, above the 2,148-participant average among 65 other Health Behavior trials with a reported enrollment target (14% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01415492, a NA study of Health Behavior and Risk Reduction Behavior, has completed, sponsored by Dana-Farber Cancer Institute.

COMPLETED
Registry status
NA
Development phase
2,440 participants
Enrollment target
1
Study location

Study Summary

This study (aka Healthy Directions2 or HD2) builds on an earlier study titled Healthy Directions (aka Healthy Directions 1 or HD1). HD1 was an intervention designed to target cancer prevention among multi-ethnic populations; it led to significant improvements in the multiple risk behavior score (consumption of red meat, fruits and vegetables, and multi-vitamins). Building on the success of HD1, HD2 further expanded the intervention to include smoking and physical activity. In addition, it expanded the study goals to include increasing efficacy across all target risk behaviors, and promoting long-term maintenance of behavior change.

Primary Outcome

Change in multiple risk behavior (MRB) score at the 6- and 18-months post-intervention follow-ups. This score is a composite measure comprised of status on 5 individual risk factors: red meat intake, multi-vitamin intake, and fruit and vegetable intake, physical activity, and smoking cessation

Interventions

  • BEHAVIORAL HD2
  • BEHAVIORAL HD2+

Study Locations (1)

Massachusetts

  • Harvard Vanguard Medical Associates - Boston

Trial Details

FieldValue
Enrollment Target 2,440 participants
Start Date 2009-03
Est. Completion 2012-01
Phase NA
Dana-Farber Cancer Institute

781 total trials

What the finished NCT01415492 record still lists

NCT01415492 is an interventional study that assigns participants to a tested intervention. Its 2,440 participants enrollment target places it among the larger protocols in the corpus, above the 2,148-participant average among 65 other Health Behavior trials with a reported enrollment target (14% higher).

The record links to 2 conditions, with Health Behavior appearing as the primary indexed condition, and to 2 interventions - of which HD2 is the first listed.

NCT01415492 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT01415492 about?

NCT01415492 is a clinical study titled "Multiple Risk Behavior Intervention in Health Care Settings". This study (aka Healthy Directions2 or HD2) builds on an earlier study titled Healthy Directions (aka Healthy Directions 1 or HD1). HD1 was an intervention designed to target cancer prevention among multi-ethnic populations; it led to significant improvements in the multiple risk behavior score (con...

What is the current status of trial NCT01415492?

This trial is currently completed. It is a NA study. The enrollment target is 2,440 participants. The study started on 2009-03. Estimated completion is 2012-01.

What conditions does trial NCT01415492 study?

This clinical trial studies the following conditions: Health Behavior, Risk Reduction Behavior.

What interventions are being tested in trial NCT01415492?

The interventions under investigation include: HD2 (BEHAVIORAL), HD2+ (BEHAVIORAL).

Who is sponsoring clinical trial NCT01415492?

This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01415492 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Health Behavior

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01415492's enrollment target sits among peer trials

2,440 6th of 65 higher than 60 of 65 other Health Behavior trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Health Behavior trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06128304 · 2,436 participants · NA

    ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services

  • NCT06676904 · 2,433 participants · NA

    Neonatal Platelet Transfusion Threshold Trial

  • NCT06898593 · 2,448 participants · NA

    Enhancing Engagement by Integrating Goals and Concerns That Matter to Patients

  • NCT05345951 · 2,425 participants · NA

    Project e-PBI+ - Parent Intervention to Reduce College Student Drinking and Cannabis Use

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01415492, the US trial registry maintained by the National Library of Medicine. NCT01415492 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.